Envoy Medical Receives Nasdaq Listing Exception

Envoy Medical, Inc. (NASDAQ: COCH) announced that the Nasdaq Hearings Panel has granted the company an exception to demonstrate compliance with the $35 million market value of listed securities requirement by February 23, 2026. The company had previously received a notice of non-compliance in February 2025 and requested a hearing with the Panel. The Panel considered recent equity capital raises, debt extinguishment, and FDA approval for the final stage of the Acclaim® cochlear implant clinical trial in its decision. Envoy Medical will continue to provide updates on its compliance progress.